Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and <i>O</i> 6-methylguanine-DNA methyltransferase activityTerzah M. Horton, Stacey L. Berg|Molecular Cancer Therapeutics|2009Cited by 84
Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).Alice A. Lee, D. Williams Parsons, P. Mickey Williams et al.|Journal of Clinical Oncology|2023Cited by 18